Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-treatment With Azithromycin to Reduce Immunogenicity to Anti-Tumor Necrosis Factor-α Agents in Patients With Crohn's Disease

NCT05599347 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT05599347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05599347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-treatment With Azithromycin to Reduce Immunogenicity to Anti-Tumor Necrosis Factor-α Agents in Patients With Crohn's Disease
Lead sponsor
Rambam Health Care Campus
Phase
Phase 2
Overall status
Recruiting
Start date
April 24, 2023
Completion date
September 10, 2027
Enrollment
180 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

biological substance; adverse effect, crohn's disease relapse